Found: 16
Select item for more details and to access through your institution.
Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer.
- Published in:
- Journal of Extracellular Vesicles, 2023, v. 12, n. 7, p. 1, doi. 10.1002/jev2.12338
- By:
- Publication type:
- Article
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810503
- By:
- Publication type:
- Article
Hepatocyte size fractionation allows dissection of human liver zonation.
- Published in:
- Journal of Cellular Physiology, 2021, v. 236, n. 8, p. 5885, doi. 10.1002/jcp.30273
- By:
- Publication type:
- Article
Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059896
- By:
- Publication type:
- Article
Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059896
- By:
- Publication type:
- Article
Multicellular ovarian cancer spheroids: novel 3D model to mimic tumour complexity.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-73680-6
- By:
- Publication type:
- Article
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5867, doi. 10.3390/cancers14235867
- By:
- Publication type:
- Article
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 2, doi. 10.3390/cancers14010002
- By:
- Publication type:
- Article
ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5563, doi. 10.3390/cancers13215563
- By:
- Publication type:
- Article
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2039, doi. 10.3390/cancers13092039
- By:
- Publication type:
- Article
Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab.
- Published in:
- Journal of Cellular & Molecular Medicine, 2023, v. 27, n. 3, p. 379, doi. 10.1111/jcmm.17658
- By:
- Publication type:
- Article
Inhibition of ADAM17 increases the cytotoxic effect of cisplatin in cervical spheroids and organoids.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1432239
- By:
- Publication type:
- Article
A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes.
- Published in:
- Archives of Toxicology, 2019, v. 93, n. 3, p. 819, doi. 10.1007/s00204-018-2375-9
- By:
- Publication type:
- Article
Generation of a Specific Fluorescence In Situ Hybridization Test for the Detection of Ovarian Carcinoma Cells.
- Published in:
- Biomedicines, 2024, v. 12, n. 6, p. 1171, doi. 10.3390/biomedicines12061171
- By:
- Publication type:
- Article
The Aza-Analogous Benzo[c]phenanthridine P8-D6 Acts as a Dual Topoisomerase I and II Poison, thus Exhibiting Potent Genotoxic Properties.
- Published in:
- Molecules, 2020, v. 25, n. 7, p. 1524, doi. 10.3390/molecules25071524
- By:
- Publication type:
- Article
Assessing the Phenotype of a Homologous Recombination Deficiency Using High Resolution Array-Based Comparative Genome Hybridization in Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17467, doi. 10.3390/ijms242417467
- By:
- Publication type:
- Article